Home > Income Statement > MANKIND PHARMA

MANKIND PHARMA
Appropriations

    Back to Income Statement
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹9,925 Cr₹801,705 Cr₹6,737 Cr₹533 Cr₹44,380 Cr

What is the latest Appropriations of MANKIND PHARMA ?

The latest Appropriations ratio of MANKIND PHARMA is ₹9,925 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹9,925 Cr
Mar2024₹801,705 Cr
Mar2023₹6,737 Cr
Mar2022₹533 Cr
Mar2021₹44,380 Cr

How is Appropriations of MANKIND PHARMA Trending?

Years Appropriations % Change
Mar2025 ₹9,925 Cr
-98.76
Mar2024 ₹801,705 Cr
11,800.05
Mar2023 ₹6,737 Cr
1,163.76
Mar2022 ₹533 Cr
-98.80
Mar2021 ₹44,380 Cr -

Compare Appropriations of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹82,033.7 Cr -5.5% -2% -11.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-5.5%

-2%

-11.1%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses